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Abstract
Introduction: Idiopathic generalised epilepsy (IGE) refers to a group of epilepsies 
resulting from the activation of neurons in the whole brain. This study aimed to evaluate the 
metabolite changes in thalamus as diagnostic biomarkers in IGE patients compared to healthy 
individuals using magnetic resonance spectroscopy (MRS) technique. 
Methods: The MRS was performed on 35 IGE patients (26 women and 11 men) with 
average age of 32 (ranged from 18 to 43) and 35 healthy individuals (13 women and 22 men) with 
average age of 31 (ranged from 21 to 50) as the control group. The levels of N-acetylaspartate 
(NAA), creatine (Cr) and choline (Cho) were measured using MRS. The NAA/Cr and NAA/Cho 
ratios were calculated for all participants. These values were statistically compared using t-test 
between the groups.
Results: The NAA had significant lower values in IGE patients, 9.6 (SD = 0.8) and 9.9 
(SD = 0.7) for right and left thalamus, respectively, compared to 10.9 (SD = 0.9) and 10.7 (SD = 
0.9) in control group. The Cr values in the left side of thalamus were significantly higher in IGE 
patients (6.7 [SD = 0.8] versus 5.8 [SD = 0.5]); however, there was no difference in right thalamus. 
Measurements showed no difference for amounts of Cho between the groups in both sides of 
thalamus. The NAA/Cr ratio was 1.48 (SD = 0.14) and 1.48 (SD = 0.16) for right and left thalamus, 
respectively, in IGE patients in comparison with 1.83 (SD = 0.2) and 1.86 (SD = 0.26) in controls. 
There was no meaningful variation between the NAA/Cho ratio of the right and left thalamus 
among the groups.
Conclusion: Thalamic NAA, Cr and NAA/Cr ratio values in IGE patients showed statistical 
differences compared to healthy individuals. Evaluating metabolites variations in thalamus using 
MRS is suggested for differentiating IGE patients from healthy individuals.
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Introduction 
A seizure is a process that occurs as a 
result of abnormal, excessive and synchronous 
electrical depolarisation of a group of central 
neurons in brain. The diagnosis of epilepsy is 
made when seizure attacks are repeated due to a 
chronic background process (1).
Idiopathic generalised epilepsy (IGE) 
refers to a group of epilepsies resulting from the 
activation of neurons in the whole-brain (2). This 
type of epilepsy shows more side effects due to its 
resistance to medical treatments. The diagnosis 
of IGE is based on strict clinical guidelines and 
electroencephalogram (EEG) as proposed by the 
International League Against Epilepsy (ILAE). 
IGE is more common in the first or second 
decade of life; although, it may be present in any 
ages (3, 4). The patients suffer from epilepsy, 
might return to normal life situation after 
surgical operations on the seizure foci resistant 
against drug treatment. Therefore, the major 
part of efforts in epilepsy diagnosis is focusing on 
seizure foci detection.
Magnetic resonance imaging (MRI) has 
become one of the useful diagnostic techniques 
for high-resolution structural imaging in 
epilepsy (5). Magnetic resonance spectroscopy 
(MRS) is a non-invasive imaging strategy to 
provide metabolic information from different 
body tissues, especially in human brain. MRS 
is a diagnostic technique which can assess the 
neurochemical changes in a given brain region of 
interest. The detection of the chemical molecules 
has been valuable for understanding the 
presence of neuronal elements, cell proliferation 
and degradation. MRI and MRS rely on the 
same physics and interactions to gather 
magnetic resonance (MR) signals; however, 
they have some differences in data processing, 
data displaying and interpretation. Data are 
presented as spectrum plots in MRS (6). Various 
metabolites can be detected in these spectrums. 
Three major peaks characterise long-echo time 
MRS spectra: N-acetylaspartate (NAA) (marker 
of neuronal and axonal viability, and density), 
creatin (Cr) (used as internal reference, since it is 
the most stable cerebral metabolite) and choline 
(Cho) (reflecting cellular proliferation) (7).
The thalamus plays a central role in cortical 
synchronisation (8) [for a review, see (9)]. 
The function of thalamus is vital for sensory, 
motor and cognitive functions, therefore, it has 
been the subject of many neurological studies. 
Experimental animal studies of generalised 
epilepsy confirmed that the thalamo-cortical 
circuitry is involved in spike and wave discharge 
generation (10). According to these studies, 
a dysfunction in reticular thalamic neurons 
may alter the electro-responsiveness of the 
developing thalamo-cortical system and cause a 
persistent state of abnormal excitation (9). Study 
of thalamus provides a valuable information 
regarding the role of thalamus in generalised 
epilepsy and electrophysiological data as the 
major mechanism of IGE (11, 12). 
The neurochemical abnormalities reflect 
thalamo-cortical dysfunction reported in 
Bernasconi et al. (11) study, therefore, measuring 
the amount of thalamus metabolites such as 
NAA, Cho and Cr can be a way of early diagnosis 
of epilepsy (13). 
MRS can assist some pathophysiological 
approaches and seizure generating mechanisms 
and also play a remarkable role in applied 
research studies aimed at examining the early 
seizure disorder processes (7, 14). In addition, 
MRS able to detect metabolic disorders which 
are invisible to a typical MRI procedure. 
Previous studies (11, 12, 15–17) focused 
on the changes of NAA and NAA/Cr values 
of thalamus in IGE patient, therefore, it was 
proposed to assess the thalamus Cr, Cho and 
NAA/Cho values in IGE patients in future 
researches. Due to the lack of human studies 
assessing the thalamus metabolites changes 
in IGE patients, the aim of this study was to 
evaluate and compare the thalamus metabolites 
in IGE sufferers using MRS technique in patients 
and healthy groups. 
Methods 
Subjects
The present cross-sectional study was 
carried out (between June 2018 and February 
2019) on 70 individuals; 35 IGE patients whose 
illness had been established based on the seizure 
history and the EEG findings. The sample size 
was determined based on previous studies (11, 
13). The average age of patients and healthy 
(control) groups were 32 (ranged from 18 to 
43) and 31 (ranged from 21 to 50), respectively. 
The patient’s demographic information has 
been illustrated in Table 1. The patients were 
randomly selected from the database of patients 
referred to the epilepsy centre of Shohadey-e-
Tajrish Hospital (Tehran, Iran). The patients and 
control groups had a normal morphologic cranial 
Malays J Med Sci. Jan–Feb 2020; 27(1): 78–86
www.mjms.usm.my80
MRI images. None of the patients had a seizure 
24 h before MR scan. All individuals were right-
handed. 
All of the patients consumed their anti-
epileptic drug during MRS investigation which 
were on various pharmacotherapy programmes: 
valproate (13 patients); a combination of 
valproate and lamotrigine (9 patients); a 
combination of valproate, lamotrigine and 
carbamazepine (7 patients); carbamazepine 
(6 patients) and their disease duration were 
5 years, 1 year and 7 months, 2 years and 
4 months, and 12 years, respectively. The 
patients received their prescribed medication 
process as in the past. There was not any history 
of mental or neurological problems in healthy 
individuals. Informed consent was obtained from 
all participants after the procedures were fully 
explained and the study received the approval 
of the national ethics committee with the 
registration number of IR.YUMS.REC.1396.148. 
Diagnostic and therapeutic methods had not any 
changes in patients group compared to regular 
methods in our study. MRI and MRS scans had 
not been reported to have any side effects (11, 13).
Table 1. Individual demographics (n = 70)
Variables IGE Patients (n = 35)n (%)
Control (n = 35)
n (%)
Total
n (%)
Age (years) a 32 (5.2) 31 (6.1) 31.5 (5.7)
  Gender Male 11 (31.4) 22 (62.9) 33 (47.1)
Female 24 (68.6) 13 (37.1) 37 (52.9)
Note: a mean (SD)
MRI Protocol 
A Siemens Avanto MRI machine (Siemens 
Healthineers, Germany) with the magnetic 
field power of 1.5-T was used along with Syngo 
computer software (Siemens Healthineers, 
Germany) to process the data. In an ideal 
situation, this machine has a field consistency 
of 1 ppm for 50 cm and magnetic stability 
of 0.1 ppm. An 8-channel MRI coil was 
utilised for transmitting and receiving the MR 
electromagnetic signals. 
To minimise the positioning variations 
of the head, patients were positioned by the 
same operator using the orbito-meatal line as a 
landmark. Incidence of possible seizure during 
the scan was evaluated based on the patient 
reports and under the continuous supervision of 
a physician. 
The routine protocols including T1-
weighted, T2-weighted and T2-trim were used 
to create coronal, sagittal and axial images. The 
MRI protocol consisted of axial T2-weighted 
fast spin echo images [time of echo (TE) = 56 
ms, time of repetition (TR) = 2500 ms and field 
of view (FOV) = 24 cm with 3 mm thickness] 
and axial T1-weighted three dimensional spoiled 
gradient recalled acquisition in the steady state 
(GRASS) images (TE = 7 ms, TR = 23 ms, flip 
angle (FA) = 50°, FOV = 24 cm with 124–156 
slice partitions of 1 mm thickness and two 
number of excitations (NEX). T2-tirm dark 
fluid images with TI = 2027 ms, TR = 6000 
ms, TE = 88 ms and FA = 150° were obtained. 
The voxels of interest (VOI) were adjusted to 
individual anatomy on images to cover the right 
thalamus, right cerebellum, prefrontal cortex and 
occipital cortex based on a protocol proposed in a 
previous study by Savic et al. (18).
MRS Protocol 
MRS with the point-resolved spectroscopy-
chemical shift imaging (PRESS-CSI) technique 
was performed as following parameters: VOI 
= 3.35 mm × 2.8 mm × 2.8 mm, NEX = 2, 
number of repetition (NR) = 15, scan time = 
6 min + 28 s, TE = 99 ms, TR = 4900 ms, TI = 
2027 ms and total examination time = 44 min. 
Raw data and images were stored on the MRI 
system computer. These data were transferred to 
another computer for subsequent analysis. These 
routine MRI images were used as a positioning 
matrix for measuring spectrogram and for 
determination of the VOI positions. In Figure 1, 
the adjusted VOI position of left thalamus was 
shown.
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Figure 1. Placement of the VOI on the left thalamus
The magnetic field homogenisation 
was done manually at the beginning of every 
protocol. Water suppression pulses were applied 
automatically and the pre-saturation bands 
were placed around the VOI area in order to 
remove fat and extraneous signals from the 
tissues around the VOI. The obtained spectral 
data was processed by the computer software 
and the results were evaluated based on the 
area under the curve of metabolite peaks. The 
metabolite concentrations in absolute units 
of mmol/L (mM) for the NAA, Cr and Cho 
were measured based on the MRS spectrum 
analysis. The metabolite concentrations values 
were analysed using the free nuclear magnetic 
resonance-spectra calculation using operators 
(NMR-SCOPE) software (Institute of Scientific 
Instruments, Czech Republic). This software has 
the ability to analyse the peaks of all metabolites 
(10). 
Post-processing of the raw MRS data for 
obtaining the 32×32 profiles, followed by a mild 
Gaussian k-space filter and an inverse Fourier 
transformation for both water-suppressed and 
unsuppressed MRS data. Artifacts present in 
the time domain water-suppressed signal due to 
static magnetic field inhomogeneities and time-
varying gradients were corrected by dividing the 
water-suppressed MRS signal by the non-water-
suppressed signal (19), a procedure that does not 
affect relative signal intensities.
Statistics
The NAA/Cr and NAA/Cho ratios resulted 
from the right and left thalamus in IGE patients 
and control group were calculated and compared 
using independent t-test in the IBM SPSS 
software version 11.5 (SPSS Inc., Chicago, IL, 
USA). Statistical significance was assumed as 
P-values < 0.05.  
Results
Thalamus metabolites including NAA, 
Cr and Cho were measured in both sides in 
IGE patients and control group. Mean and 
standard deviation (SD) values, the comparison 
of these metabolites, and NAA/Cr and NAA/ 
Cho ratios are shown in Table 2. A sample of 
the MRS spectrum obtained from a patient 
is illustrated in Figure 2. The statistical tests 
showed that all of the metabolites did not have 
any significant differences between the right 
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and left side of thalamus inside the groups. 
NAAs have significant lower values in IGE 
patients compared to healthy group (P-value = 
0.01). The Cr values in the left side of thalamus 
showed remarkable higher values in IGE patients 
(P-value = 0.032); however, there was no 
difference in Cr values in right thalamus between 
IGE patients and healthy individuals. Amount of 
Cho showed no difference between the groups in 
both sides of thalamus.
Table 2. Comparison of NAA, Cr and Cho values, and also NAA/Cr and NAA/Cho ratios in both sides of 
thalamus between IGE patients and control groups
Variable
Mean (SD)
Mean differences 
(95% CI)
P-valueRight thalamus of 
patients (n = 35)
Right thalamus of 
control (n = 35)
NAAa (mM/L) 9.6 (0.8) 10.9 (0.9) 1.3 (1, 1.61) 0.01
Crb (mM/L) 6.5 (0.6) 6.0 (0.7) 0.5 (0.32, 0.73) 0.12
Choc (mM/L) 1.8 (0.4) 1.8 (0.4) 0.1 (0, 0.11) 0.45
NAA/Cr 1.47 (0.11) 1.70 (0.20) 0.34 (0.25, 0.43) < 0.0001
NAA/Cho 5.33 (0.71) 6.05 (0.70) 0.71 (0.53, 0.89) 0.17
Left thalamus of 
patients (n = 35)
Left thalamus of 
control (n = 35)
Mean differences 
(95% CI)
P-value
NAAa (mM/L) 9.9 (0.7) 10.7 (0.9) 0.8 (0.4, 0.95) 0.01
Crb (mM/L) 6.7 (0.8) 5.8 (0.5) 1.2 (0.92, 1.51) 0.032
Choc (mM/L) 1.6 (0.3) 1.9 (0.6) 0.3 (0.21, 0.42) 0.23
NAA/Cr 1.47 (0.15) 1.84 (0.25) 0.38 (0.28, 0.49) 0.001
NAA/Cho 6.18 (0.72) 5.63 (0.70) 0.55 (0.41, 0.70) 0.11
Notes:  a = N-acetylaspartat; b = Cr; c = Cho
Figure 2. MRS spectra from a left side of thalamus in IGE patient
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This study also evaluated the NAA/Cho 
ratios in the right and left thalamus. The results 
of the study showed that there was no significant 
difference between the NAA/Cho ratios in the 
IGE patients and control groups (Table 2 and 
Figure 4).
Figure 3. Comparison of NAA/Cr mean ratios in thalamus between IGE patients and control groups (P-values 
resulted from the t-test were shown above the compared groups. Error bars represent the standard 
deviations)
Figure 4. Comparison of NAA/Cho mean ratios in thalamus between IGE patients and control groups (P-values 
resulted from the t-test were shown above the compared groups. Error bars represent the standard 
deviations)
The SD values of the NAA/Cr ratios in the 
right and left thalamus in both IGE and healthy 
participants were measured and presented 
in Table 2 and Figure 3. The ratio of NAA/Cr 
among IGE patients was significantly lower 
than the healthy individuals (P-value ≤ 0.001). 
The average NAA/Cr ratio in the right and left 
thalamus in healthy participants were higher in 
comparison with those sides of thalamus in IGE 
patients.
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Discussion 
We found that changes in thalamus 
metabolites (NAA, Cr and NAA/Cr values) 
are the appropriate diagnostic biomarkers 
for differentiating IGE patients from healthy 
individuals using MRS technique. 
In a study by Savic et al. (18) using a single-
voxel spectroscopy (SVS) method, it showed that 
the NAA value in thalamus of idiopathic patients 
was lower compared with healthy people (9.7 
[SD = 1.0] versus 10.8 [SD = 0.9]). In that study, 
they used a SVS method and did not assess the 
metabolites ratios like NAA/Cr. 
In the current study, the multi-voxel 
methodology was used and the metabolite ratios 
in both side of thalamus were measured. In 
SVS technique, a single spectrum was acquired 
from a definite volume of tissue as an integral 
(12, 15, 17). Although this technique is fast and 
a spectrum is easily acquired, it provides low 
information about the organs’ metabolites (15). 
By contrast, the multi-voxel technique combining 
features of MRI and MRS data from multiple 
adjacent voxels covering a big volume of an 
organ (15).
The results of our study demonstrated that 
the value of NAA and NAA/Cr in the thalamus 
of IGE patients is significantly lower (P-value 
< 0.01) compared to healthy individuals. Since 
NAA is measured in a voxel, a reduction in 
NAA reflects a loss of nerve cells or axons, as 
well as neural damage and a disorder in body 
metabolism (11). 
In this study, some evidence was found 
about the relationship between the metabolic 
changes and neural activity of thalamus in 
IGE patients as the main foundation of seizure 
generation in this type of epilepsy. Nevertheless, 
it was not determined whether the thalamus 
functioning disorder is specific to IGE or 
not. This is because in general, no structural 
damage was found in routine MRI images as a 
foundational area for epilepsy focus. The analysis 
of the spectrogram obtained through multi-voxel 
MRS method showed a remarkable decrease 
in the NAA and NAA/Cr ratio in the thalamus 
of IGE patients. We also found that the Cr 
value was higher in IGE patients in comparison 
with healthy individuals just in the left side of 
thalamus. This metabolite usually was used as 
internal reference, since it is the most stable 
cerebral metabolite. Therefore, higher values 
of Cr in IGE patients can indicate the neural 
problems. Previous studies (11, 12, 16) focused 
on the changes in NAA and NAA/Cr values for 
IGE patient thalamus; therefore, it is proposed to 
study the changes of thalamus Cr values in IGE 
patients in future researches.
In a study, Fojtiková et al. (16) reported 
that thalamic NAA/Cr ratio is significantly 
lower in patients with typical absence epilepsy 
in comparison with healthy group. In another 
study by Bernasconi et al. (11), the mean 
value of thalamic NAA/Cr in IGE patients 
group was lower compared to control healthy 
individuals. There was no difference in 
NAA/Cr between patients whose seizures 
were well controlled and those not controlled. 
They expressed that the thalamic dysfunction 
may occur regardless of amount of wave and 
spike activity. Doelken et al. (15) reported that 
NAA and Glx (glutamate + glutamine) metabolite 
values differ in IGE patients compared to healthy 
people. We found the similar results in our 
study. Furthermore, we evaluated the NAA and 
Cr values and a significant difference between 
the groups was obtained. The Glx or other 
metabolites were not evaluated because these 
metabolites have lower peaks in comparison with 
NAA, Cr and Cho peak values. The MR spectrum 
is along with noise and random errors, therefore, 
measuring high peak values in MRS like NAA, 
Cr, and Cho are less affected by noises and errors 
(20, 21).
According to the findings of this study and 
matching them with the clinical data of patients, 
thalamus plays a key role in the generation of 
seizures in IGE which means the presence of 
thalamo-cortical anomalies as a pathophysiologic 
foundation for IGE.
In this study, different time and locations 
for gathering the MRS data were the limitations. 
Furthermore, differences in therapeutic 
modalities, like various pharmacotherapy 
programs, may affect the results of our study.   
Regarding the results of this study and 
previous researches (11, 12, 16, 17), it is suggested 
that more studies have to be conducted 
with respect to using the MRS technique for 
diagnosing various types of epilepsy. In addition, 
similar studies could be performed on a bigger 
group of patients to prove the efficiency of the 
MRS in diagnosis of epilepsy.  
Conclusion
Our results demonstrated certain altered 
metabolite values in IGE patients compared 
to healthy individuals. Thalamic NAA, Cr and 
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NAA/Cr ratio values showed significant 
differences in IGE patients. Therefore, MRS 
of thalamus in patients is suggested for 
differentiating the IGE patients from healthy 
individuals.
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